Avexegen Therapeutics develops revolutionary therapies to promote gastro-intestinal health for patients with GI disorders. They offer an approach to directly heal damaged and inflamed gut tissue in patients with crohns disease and ulcerative colitis, as well as in premature infants with necrotizing enterocolitis.